Upregulation of Endothelial Nitric Oxide Synthase and Endothelin-1 in Pulmonary Hypertension Secondary to Heart Failure in Aorta-Banded Rats

Pediatric Pulmonology

Volumn 37, Issue 3, 2004, Pages 249-256

  Dai, Zen Kong ^a   Tan, Mian Shin ^a   Chai, Chee Yin ^a   Yeh, Jwu Lai ^a   Chou, Shah Hwa ^a   Chiu, Chaw Chi ^a   Jeng, Arco Y ^b   Chen, Ing Jun ^a   Wu, Jiunn Ren ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Aortic banding; Endothelial nitric oxide synthase; Endothelin 1; Heart failure; Pulmonary hypertension; Pulmonary vascular remodeling

Indexed keywords

COMPLEMENTARY DNA; ENDOTHELIN 1; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; HEART FAILURE; HEART HYPERTROPHY; HEMODYNAMIC PARAMETERS; IMMUNOHISTOCHEMISTRY; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; M MODE ECHOCARDIOGRAPHY; MEAN ARTERIAL PRESSURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; AORTA; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; MALE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR; UP-REGULATION;

EID: 1542343885     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10413     Document Type: Article

References (35)

1. Meininger GA, Davis MJ. Cellular mechanisms involved in the vascular myogenic response. Am J Physiol 1992;263:647-659.
2. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1993;330:1431-1438.
3. Keck EW. Pulmonary hypertension and pulmonary vascular disease in congenital heart defects. Z Kardiol 1989;78:65-73.
4. Yamaki S, Endo M, Takahashi T. Different grades of medial hypertrophy and intimal changes in small pulmonary arteries among various types of congenital heart disease with pulmonary hypertension. Tohoku J Exp Med 1997;182:83-91.
5. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-666.
6. Miyazaki H, Kondoh M, Watanabe H, Yanagisawa M, Masaki T, Murakami K. Two different forms of endothelin receptors in rat lung. FEBS Lett 1989;257:208-210.
7. Xue C, Johns RA. Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodelling in the hypoxia. Hypertension 1996;28:743-753.
8. Li H, Chen SJ, Chen YF, Meng QC, Durand J, Suzanne O, Elton TS. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J Appl Physiol 1994;77:1451-1459.
9. Shaul PW, North AJ, Brannon TS, Ujiie K, Wells LB, Nisen PA, Lowenstein CJ, Snyder SH, Star RA. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol 1995;13:167-174.
10. Le Cras TD, Tyler RC, Xue C, Rengasamy A, Johns RA. Chronic hypoxia upregulates endothelial and inducible nitric oxide synthase gene and protein expression in rat lung. Am J Physiol 1996;270:164-170.
11. Black SM, Fineman JR, Steinhorn RH, Bristow J, Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 1998;275:1643-1651.
12. Pfeifer M, Bruckschlegel G, Holmer SR, Paul M, Reigger AJG, Schunker H. Reciprocal regulation of pulmonary and cardiac angiotensin-converting enzyme in rats with severe left ventricular hypertrophy. Cardiovasc Res 1998;38:125-132.
13. I3. Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG Jr, Meyer TE. Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens 1998;16:1813-1822.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
15. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 2000;102:1718-1723.
16. Chen YF, Oparil S. Endothelial dysfunction in the pulmonary vascular bed. Am J Med Sci 2000;320:223-232.
17. Dai ZK, Tan MS, Chai CY, Chen IJ, Jeng AY, Wu JR. Effects of increased pulmonary flow on the expression of endothelial nitric oxide synthase and endothelin-1 in rats. Clin Sci 2002;103:289-293.
18. Xue C, Johns RA. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:1642-1644.
19. Itani MM, Talerico MG, Pino PA, Burke-Wolin T. Early regulatory changes in rat pulmonary artery of renin-dependent systemic hypertension models. Am J Respir Cell Mol Biol 1996;15:467-472.
20. Driss AB, Devaux C, Henrion D, Duriez M, Thuillez C, Levy BI, Michel JB. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000;101:2764-2770.
21. Mason NA, Springall DR, Burke M, Pollock J, Mikhail G, Yacoub MH, Polak JM. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 1998;185:313-318.
22. Kim H, Yung JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN. Endothelin mediates pulumonary vascular remodeling in a canine model of chronic embolic pulmonary hypertension. Eur Respir J 2000;15:640-648.
23. Ishikawa S, Miyauchi T, Askai S. Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair. J Thorac Cadiovasc Surg 1995;110:271-273.
24. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-1739.
25. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-509.
26. Sakai ET, Miyauchi T, Sakura T, Yamagauchi I, Kobayashi M, Goto K, Sugishita Y. Pulmonary hypertension caused by congestive heart failure is ameliorated by long term application of an endothelin receptor antagonist. J Am Coll Cardiol 1996;28:1580-1588.
27. Fineman JR, Wong J, Mikhailov T, Vanderford PA, Jerome HE, Soifer SJ. Altered endothelial function in lambs with pulmonary hypertension and acute lung injury. Pediatr Pulmonol 1999;27:147-156.
28. Filep JG, Foldes-Filp E, Rousseau A, Sirois P, Fournier A. Vascular response of endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat. Br J Pharmacol 1993;110:1213-1221.
29. Bodi I, Bishopric NH, Discher DJ, Wu X, Webster KA. Cell-specificity and signaling pathway of enodthelin-1 gene regulation by hypoxia. Cardiovasc Res 1995;30:975-984.
30. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993;92:99-104.
31. Prie S, Stewart DJ, Dupuis J. Endothelin A receptor blockade improves nitric oxide-mediated vasodilatation in monocrotaline-induced pulmonary hypertension. Circulation 1998;97:2169-2174.
32. Bouloumie A, Bauersachs J, Linz W, Scholkens BA, Wiemer G, Fleming I, Busse R. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 1997;30:934-941.
33. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y, Inoue N, Hirata K, Akita H, Yokoyama M. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 2000;36:97-102.
34. Mathew R, Zeballos GA, Tun H, Gewitz MH. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats. Cardiovasc Res 1995;30:739-746.
35. Deuchar GA, Docherty A, MacLean MR, Hicks MN. Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric oxide and endothelin-1 in the control of pulmonary vascular tone. Br J Pharmacol 2002;135:1060-1068.